These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7608483)
1. Blunted natriuresis and abnormal systemic hemodynamic responses to C-type and brain natriuretic peptides in rats with cirrhosis. Komeichi H; Moreau R; Cailmail S; Gaudin C; Lebrec D J Hepatol; 1995 Mar; 22(3):319-25. PubMed ID: 7608483 [TBL] [Abstract][Full Text] [Related]
2. Blunted systemic, splanchnic, and renal hemodynamic responses to atrial natriuretic peptide in rats with cirrhosis. Ohsuga M; Moreau R; Hartleb M; Komeichi H; Lebrec D J Hepatol; 1994 Jan; 20(1):91-6. PubMed ID: 8201228 [TBL] [Abstract][Full Text] [Related]
3. Blunted natriuretic response to low-dose brain natriuretic peptide infusion in nonazotemic cirrhotic patients with ascites and avid sodium retention. La Villa G; Riccardi D; Lazzeri C; Casini Raggi V; Dello Sbarba A; Tosti Guerra C; Fronzaroli C; Foschi M; Laffi G; Gentilini P Hepatology; 1995 Dec; 22(6):1745-50. PubMed ID: 7489983 [TBL] [Abstract][Full Text] [Related]
4. Comparative bioactivity of atrial, brain, and C-type natriuretic peptides in conscious sheep. Charles CJ; Espiner EA; Richards AM; Nicholls MG; Yandle TG Am J Physiol; 1996 Jun; 270(6 Pt 2):R1324-31. PubMed ID: 8764300 [TBL] [Abstract][Full Text] [Related]
5. Role of altered systemic hemodynamics in the blunted renal response to atrial natriuretic peptide in rats with cirrhosis and ascites. López C; Jiménez W; Arroyo V; La Villa G; Gaya J; Clària J; Rivera F; Rodés J J Hepatol; 1989 Sep; 9(2):217-26. PubMed ID: 2530268 [TBL] [Abstract][Full Text] [Related]
6. Activation of myocardial and renal natriuretic peptides during acute intravascular volume overload in dogs: functional cardiorenal responses to receptor antagonism. Borgeson DD; Stevens TL; Heublein DM; Matsuda Y; Burnett JC Clin Sci (Lond); 1998 Aug; 95(2):195-202. PubMed ID: 9680502 [TBL] [Abstract][Full Text] [Related]
7. C-type natriuretic peptide in chronic renal failure and its action in humans. Igaki T; Itoh H; Suga S; Hama N; Ogawa Y; Komatsu Y; Mukoyama M; Sugawara A; Yoshimasa T; Tanaka I; Nakao K Kidney Int Suppl; 1996 Jun; 55():S144-7. PubMed ID: 8743538 [TBL] [Abstract][Full Text] [Related]
8. Increased plasma levels and blunted effects of brain natriuretic peptide in rats with congestive heart failure. Hoffman A; Grossman E; Keiser HR Am J Hypertens; 1991 Jul; 4(7 Pt 1):597-601. PubMed ID: 1831369 [TBL] [Abstract][Full Text] [Related]
9. Clearance receptors and endopeptidase: equal role in natriuretic peptide metabolism in heart failure. Rademaker MT; Charles CJ; Kosoglou T; Protter AA; Espiner EA; Nicholls MG; Richards AM Am J Physiol; 1997 Nov; 273(5):H2372-9. PubMed ID: 9374774 [TBL] [Abstract][Full Text] [Related]
10. Renal and vascular effects of C-type and atrial natriuretic peptides in humans. Pham I; Sediame S; Maistre G; Roudot-Thoraval F; Chabrier PE; Carayon A; Adnot S Am J Physiol; 1997 Oct; 273(4):R1457-64. PubMed ID: 9362312 [TBL] [Abstract][Full Text] [Related]